Search research articles
Contact Us
Filters
Showing results (21-30 of 46) with videos related to
Page
of 5
Sort By:
Clinical and Translational Science
|
May 26, 2022
Pharmacokinetics of asciminib in the presence of CYP3A or P-gp inhibitors, CYP3A inducers, and acid-reducing agents
Matthias Hoch, Felix Huth, Masahiko Sato, et al.
Cancer Chemotherapy and Pharmacology
|
July 21, 2019
Multiple administrations of fluconazole increase plasma exposure to ruxolitinib in healthy adult subjects
Vassilios Aslanis, Kenichi Umehara, Felix Huth, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
March 5, 2022
Novel Bruton's tyrosine kinase inhibitor remibrutinib: Assessment of drug-drug interaction potential as a perpetrator of cytochrome P450 enzymes and drug transporters and the impact of covalent binding on possible drug interactions
Hilmar Schiller, Felix Huth, Carole Schuhler, et al.
Clinical and Translational Science
|
August 25, 2021
Novel Bruton's Tyrosine Kinase inhibitor remibrutinib: Drug-drug interaction potential as a victim of CYP3A4 inhibitors based on clinical data and PBPK modeling
Felix Huth, Hilmar Schiller, Yi Jin, et al.
European Journal of Clinical Pharmacology
|
August 15, 2018
Siponimod pharmacokinetics, safety, and tolerability in combination with rifampin, a CYP2C9/3A4 inducer, in healthy subjects
Anne Gardin, Cathy Gray, Srikanth Neelakantham, et al.
Marine Biotechnology (New York, N.Y.)
|
February 13, 2004
Characterization of surfactin-like cyclic depsipeptides synthesized by Bacillus pumilus from ascidian Halocynthia aurantium
Natalie I Kalinovskaya, Tatyana A Kuznetsova, Elena P Ivanova, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
October 3, 2022
Time matters - <i>in vitro</i> cellular disposition kinetics help rationalizing cellular potency disconnects
Birk Poller, Sophie Werner, Norbert Domange, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
February 19, 2016
Esterase phenotyping in human liver in vitro: specificity of carboxylesterase inhibitors
Ken-Ichi Umehara, Markus Zollinger, Elizabeth Kigondu, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
December 6, 2022
Novel insights into bile acid detoxification via CYP, UGT and SULT enzymes
Vlasia Kastrinou Lampou, Birk Poller, Felix Huth, et al.
Archives of Toxicology
|
November 14, 2024
Drug-induced cholestasis (DIC) predictions based on in vitro inhibition of major bile acid clearance mechanisms
Vlasia Kastrinou-Lampou, Raquel Rodríguez-Pérez, Birk Poller, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 46) with videos related to
Sort By:
Page
of 5
Clinical and Translational Science
|
May 26, 2022
Pharmacokinetics of asciminib in the presence of CYP3A or P-gp inhibitors, CYP3A inducers, and acid-reducing agents
Matthias Hoch, Felix Huth, Masahiko Sato, et al.
Cancer Chemotherapy and Pharmacology
|
July 21, 2019
Multiple administrations of fluconazole increase plasma exposure to ruxolitinib in healthy adult subjects
Vassilios Aslanis, Kenichi Umehara, Felix Huth, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
March 5, 2022
Novel Bruton's tyrosine kinase inhibitor remibrutinib: Assessment of drug-drug interaction potential as a perpetrator of cytochrome P450 enzymes and drug transporters and the impact of covalent binding on possible drug interactions
Hilmar Schiller, Felix Huth, Carole Schuhler, et al.
Clinical and Translational Science
|
August 25, 2021
Novel Bruton's Tyrosine Kinase inhibitor remibrutinib: Drug-drug interaction potential as a victim of CYP3A4 inhibitors based on clinical data and PBPK modeling
Felix Huth, Hilmar Schiller, Yi Jin, et al.
European Journal of Clinical Pharmacology
|
August 15, 2018
Siponimod pharmacokinetics, safety, and tolerability in combination with rifampin, a CYP2C9/3A4 inducer, in healthy subjects
Anne Gardin, Cathy Gray, Srikanth Neelakantham, et al.
Marine Biotechnology (New York, N.Y.)
|
February 13, 2004
Characterization of surfactin-like cyclic depsipeptides synthesized by Bacillus pumilus from ascidian Halocynthia aurantium
Natalie I Kalinovskaya, Tatyana A Kuznetsova, Elena P Ivanova, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
October 3, 2022
Time matters - <i>in vitro</i> cellular disposition kinetics help rationalizing cellular potency disconnects
Birk Poller, Sophie Werner, Norbert Domange, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
February 19, 2016
Esterase phenotyping in human liver in vitro: specificity of carboxylesterase inhibitors
Ken-Ichi Umehara, Markus Zollinger, Elizabeth Kigondu, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
December 6, 2022
Novel insights into bile acid detoxification via CYP, UGT and SULT enzymes
Vlasia Kastrinou Lampou, Birk Poller, Felix Huth, et al.
Archives of Toxicology
|
November 14, 2024
Drug-induced cholestasis (DIC) predictions based on in vitro inhibition of major bile acid clearance mechanisms
Vlasia Kastrinou-Lampou, Raquel Rodríguez-Pérez, Birk Poller, et al.
Page
of 5